Phase 3 TNBC - Triple-Negative Breast Cancer trials recruiting now

All TNBC - Triple-Negative Breast Cancer trials, every phase

Other phases for TNBC - Triple-Negative Breast Cancer

Phase 3 TNBC - Triple-Negative Breast Cancer trials

• A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer
  NCT05862064 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
  NCT05999149 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: Female · 2 locations
• SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC
  NCT06627712 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: Female · 1 location

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.